5-PIPERIDINO-7-(N-(N-PEPTIL)-N-(BETA-OKSIETIL)-AMINO)-S-TRIAZOLO(1,5-A)PIRIMIDINO GAVIMO BUDAS

5-PIPERIDINO-7-(N-(N-PEPTIL)-N-(BETA-OKSIETIL)-AMINO)-S-TRIAZOLO(1,5-A)PIRIMIDINO GAVIMO BUDAS

s-triazolo(1,5-a)pyrimidine compounds of the Formula (I> wherein R2 and R3 are the same or different and represent an H atom, a C1 to C3 alkyl group or a halogen atom; R4 represents a straight-chain or branched-chain C4 to C9 alkyl group, an aralkyl group substituted by one or more C1 to C3 alkox...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BLOCK,HANS-ULRICH, MENTZ,PETER, PASCHE,RUDI, BALLNUS,MARTINA, TENOR,ERNST, THOMAS,ECKEHARD, HEINROTH-HOFFMANN,INGRID, MEST,HANS-JUERGEN
Format: Patent
Sprache:lit
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:s-triazolo(1,5-a)pyrimidine compounds of the Formula (I> wherein R2 and R3 are the same or different and represent an H atom, a C1 to C3 alkyl group or a halogen atom; R4 represents a straight-chain or branched-chain C4 to C9 alkyl group, an aralkyl group substituted by one or more C1 to C3 alkoxy or alkyl groups; 2,5-dioxaheptyl or 3-oxahexyl residues; R5 represents an H atom, a C1 to C3 alkyl group, a hydroxyethyl group or a hydroxypropyl group; R6 and R7 are the same or different and represent an H atom, a straight-chain or branched-chain C1 to C5 alkyl group, or R6 and R7 together complete a cycloaliphatic ring, the substituents in positions 5 and 7 optionally being mutually exchanged, and the pharmaceutically acceptable salts thereof, their preparation and pharmaceutical compositions comprising them are disclosed as therapeutic aids for cardio-circulatory disorder.